SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-19-004653
Filing Date
2019-03-22
Accepted
2019-03-22 09:04:15
Documents
94
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2018_immucellcorp.htm 10-K 1313546
2 INCENTIVE COMPENSATION AGREEMENT DATED MARCH 21, 2019 BETWEEN THE COMPANY AND EL f10k2018ex10-21_immucell.htm EX-10.21 9307
3 CONSENT OF RSM US LLP f10k2018ex23-1_immucellcorp.htm EX-23.1 1737
4 CERTIFICATION f10k2018ex31_immucellcorp.htm EX-31 6772
5 CERTIFICATION f10k2018ex32_immucellcorp.htm EX-32 4071
  Complete submission text file 0001213900-19-004653.txt   6753882

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE iccc-20181231.xml EX-101.INS 1388527
7 XBRL SCHEMA FILE iccc-20181231.xsd EX-101.SCH 59235
8 XBRL CALCULATION FILE iccc-20181231_cal.xml EX-101.CAL 59804
9 XBRL DEFINITION FILE iccc-20181231_def.xml EX-101.DEF 184461
10 XBRL LABEL FILE iccc-20181231_lab.xml EX-101.LAB 580577
11 XBRL PRESENTATION FILE iccc-20181231_pre.xml EX-101.PRE 391558
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12934 | Film No.: 19698505
SIC: 2835 In Vitro & In Vivo Diagnostic Substances